For private equity sponsors and operators of cardiac diagnostics and monitoring businesses

Referrals, patients, devices and monitoring volume all rise. Access, clinical capacity, turnaround time, margin and cash do not move with them.

The constraint is rarely one workflow or one technology. It is the interaction among referral intake, patient activation, device logistics, data review, clinical interpretation and payer requirements.

What grows Referral sources · patients · devices · monitoring days · clinical staff · service lines
What should follow Faster activation · completed studies · higher asset utilization · shorter turnaround · clean claims · collected cash
Six leverage domains Where scale should create leverage, and why it usually does not.
Referral intake and activation
Faster order validation, authorization and activation.
Referral channels, documentation, authorization and outreach stay fragmented.
Onboarding and adherence
More studies successfully started and completed.
Setup, connectivity, wear compliance and follow-up depend on manual intervention.
Device and logistics operations
Higher asset utilization, lower cost per completed study.
Inventory, shipping, retrieval and refurbishment run in separate systems.
Review and interpretation
More data processed while preserving clinical judgment.
Signal quality, review burden and escalation rules vary by device and patient.
Reporting and escalation
Shorter turnaround; findings reach the right clinician.
Alert thresholds, handoffs and acknowledgment are inconsistent.
Revenue, quality and integration
Clean claims, timely cash, consistent performance.
Authorization, coding, quality systems and definitions remain fragmented.
The answer is not automatically more technology
The right intervention may be simplification, standardization, a shared capability, better system linkage, conventional automation or selective AI. The objective is the simplest intervention capable of changing the economics.
SCALED · how far the intervention should go An organization may stop at any stage.
S Simplify→ C Codify→ A Aggregate→ L Link→ E Execute automatically→ D Deploy AI selectively
Two decades inside regulated healthcare operations: 30+ regulated products shipped, P&L-owner. Ex-LabCorp, Deployed systems to the VA, NHS, Memorial Sloan-Kettering.
Start with one consequential question
One question involving referral conversion, patient activation, monitoring capacity, clinical review, report turnaround, margin or cash. A preliminary conversation determines whether it warrants a diagnostic.
Discuss a cardiac diagnostics value-creation question →
Arvita Tripati
Value Creation Advisor & CEO, Vahana Labs
arvita@vahanalabs.ai